Figure 4.

The effects of anti-CKLF1 antibody on expression of ICAM-1 and VCAM-1. Anti-CKLF1 antibody (0.1, 0.5 or 1 μg) was injected into the right cerebral ventricle immediately after reperfusion. ICAM-1 and VCAM-1 mRNA and protein expression were measured. Treatment with anti-CKLF1 antibody decreased the expression of ICAM-1 and VCAM-1 in ischemic brain tissue. (A) mRNA of ICAM-1, (B) mRNA of VCAM-1, (C) protein of ICAM-1, (D) protein of VCAM-1. Each data point shows the mean ± SEM for five rats. #P < 0.05, ##P < 0.01, compared with sham-operated group; *P < 0.05, **P < 0.01 compared with vehicle group.